Literature DB >> 1677951

Nuclear DNA content of medullary thyroid carcinoma in a large family with the MEN-2A syndrome.

H R Haak1, C J Cornelisse, B M Goslings, G J Fleuren.   

Abstract

Flow cytometry of medullary thyroid carcinoma (MCT) was performed in a large family with the MEN-2A syndrome. Of 15 family members with MCT five patients (10-27 yr) were without lymph node metastases. Six patients had a normal pentagastrin test after operation. All patients are alive and free of symptoms of MCT 6-9 yr after total thyroidectomy and an ablative dose of 131-I. In 12 of the 15 patients with MCT flowcytometry of paraffin-embedded tissue could be performed. The majority of all tumors (n = 9) were classified as peridiploid. Metastatic tumor, 6 years after thyroidectomy, in one of the patients was diploid. Only two MCT were clearly aneuploid. In one patient the tumor was tetraploid. We conclude that the majority of the MCT patients in this family with the MEN-2A syndrome have no or limited ploidy aberrations in their tumors, which correlates well with the favourable prognosis of familial MCT.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1677951     DOI: 10.1007/BF03346808

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  11 in total

1.  Early liver metastases in patients with medullary carcinoma of the thyroid gland.

Authors:  K M Gautvik; K Talle; B Hager; O G Jørgensen; M Aas
Journal:  Cancer       Date:  1989-01-01       Impact factor: 6.860

2.  Histopathologic characteristics and nuclear DNA content as prognostic factors in medullary thyroid carcinoma. A nationwide study in Sweden. The Swedish MTC Study Group.

Authors:  U Bergholm; H O Adami; G Auer; R Bergström; M Bäckdahl; L Grimelius; G Hansson; O Ljungberg; E Wilander
Journal:  Cancer       Date:  1989-07-01       Impact factor: 6.860

3.  Characteristics of a family with the MEN-2A syndrome.

Authors:  H R Haak; A C Nieuwenhuijzen Kruseman
Journal:  Henry Ford Hosp Med J       Date:  1987

4.  Medullary thyroid carcinoma: prognosis of familial versus nonfamilial disease and the role of radiotherapy.

Authors:  N A Samaan; P N Schultz; R C Hickey
Journal:  Horm Metab Res Suppl       Date:  1989

Review 5.  Clinical and biological significance of aneuploidy in human tumours.

Authors:  M L Friedlander; D W Hedley; I W Taylor
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

6.  Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.

Authors:  D W Hedley; M L Friedlander; I W Taylor
Journal:  Cytometry       Date:  1985-07

7.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

8.  Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients.

Authors:  M F Saad; N G Ordonez; R K Rashid; J J Guido; C S Hill; R C Hickey; N A Samaan
Journal:  Medicine (Baltimore)       Date:  1984-11       Impact factor: 1.889

9.  Tumor ploidy as a major prognostic factor in advanced ovarian cancer.

Authors:  C J Rodenburg; C J Cornelisse; P A Heintz; J Hermans; G J Fleuren
Journal:  Cancer       Date:  1987-01-15       Impact factor: 6.860

10.  Multiple endocrine neoplasia syndrome type 2: the value of screening and central registration. A study of 15 kindreds in The Netherlands.

Authors:  H F Vasen; A C Nieuwenhuijzen Kruseman; H Berkel; E K Beukers; C C Delprat; R G Van Doorn; R A Geerdink; H R Haak; W H Hackeng; H P Koppeschaar
Journal:  Am J Med       Date:  1987-11       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.